{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:36:53Z","timestamp":1790869013890,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PE00000007"],"award-info":[{"award-number":["PE00000007"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["SR\/WOSA\/LS104\/2016"],"award-info":[{"award-number":["SR\/WOSA\/LS104\/2016"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bioorg.2025.108427","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T16:46:14Z","timestamp":1743612374000},"page":"108427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Design, and synthesis of 2,4-thiazolidinedione substituted 1,3,5-triazine derivatives as anti-HIV agent via inhibition of reverse transcriptase along with anti-SARS CoV-2, antibacterial and antibiofilm activity"],"prefix":"10.1016","volume":"160","author":[{"given":"Saumya","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Gahtori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya Anurag","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sintu Kumar","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh Kumar","family":"Kumawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Raj","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Tramontano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashis","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108427_bb0005","article-title":"Global, regional, and national HIV\/AIDS disease burden levels and trends in 1990\u20132019: a systematic analysis for the global burden of disease 2019 study","volume":"11","author":"Tian","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bioorg.2025.108427_bb0010","article-title":"The immune response to SARS-CoV-2 in people with HIV","volume":"21","author":"H\u00f6ft","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bioorg.2025.108427_bb0015","doi-asserted-by":"crossref","DOI":"10.1097\/COH.0000000000000588","article-title":"HIV treatment and prevention 2019: current standards of care","volume":"15","author":"Phanuphak","year":"2020","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.bioorg.2025.108427_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-016-0120-0","article-title":"The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future","volume":"13","author":"Kay","year":"2016","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.bioorg.2025.108427_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2009.09.008","article-title":"Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009)","volume":"85","author":"de B\u00e9thune","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bioorg.2025.108427_bb0030","article-title":"Review of the impact of NNRTI-based HIV treatment regimens on patient-reported disease burden","volume":"26","author":"Simpson","year":"2014","journal-title":"AIDS Care - Psychological and Socio-Medical Aspects of AIDS\/HIV"},{"key":"10.1016\/j.bioorg.2025.108427_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295223","article-title":"Questioning the \u201cease\u201d in disease: was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV)","volume":"19","author":"Roucoux","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108427_bb0040","series-title":"Outcomes among HIV-Positive Patients Hospitalized with COVID-19, J Acquir Immune Defic Syndr (1988) 85","author":"Karmen-Tuohy","year":"2020"},{"key":"10.1016\/j.bioorg.2025.108427_bb0045","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.22486","article-title":"Threat of Staphylococcus aureus pneumonia in severe COVID-19 patients","author":"Tanaka","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.bioorg.2025.108427_bb0050","article-title":"COVID-19-associated opportunistic infections: a snapshot on the current reports","volume":"22","author":"Abdoli","year":"2022","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bioorg.2025.108427_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.103768","article-title":"COVID-19 outcomes in HIV patients: a review","volume":"78","author":"Aborode","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.bioorg.2025.108427_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2022.05.006","article-title":"Risk of mortality in HIV-infected COVID-19 patients: a systematic review and meta-analysis","volume":"15","author":"Dzinamarira","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.bioorg.2025.108427_bb0065","doi-asserted-by":"crossref","first-page":"2000363","DOI":"10.1002\/ardp.202000363","article-title":"1,3,5-Triazine: a versatile pharmacophore with diverse biological activities","volume":"354","author":"Singh","year":"2021","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2025.108427_bb0070","article-title":"Evolution of anti-HIV drug candidates. Part 2: Diaryltriazine (DATA) analogues","volume":"11","author":"Ludovici","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108427_bb0075","first-page":"3856","article-title":"Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors","author":"Liu","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108427_bb0080","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/cbdd.12471","article-title":"Design, synthesis, and anti-HIV evaluation of novel triazine derivatives targeting the entrance channel of the NNRTI binding pocket","volume":"86","author":"Chen","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.108427_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/med.20241","article-title":"HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design","volume":"33","author":"Zhan","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.108427_bb0090","doi-asserted-by":"crossref","DOI":"10.1021\/jm0004906","article-title":"2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1","volume":"vol. 44","author":"Chan","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108427_bb0095","doi-asserted-by":"crossref","DOI":"10.1021\/jm100762r","article-title":"Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore","volume":"53","author":"Fleming","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108427_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202300184","article-title":"Chemistry and applications of functionalized 2,4-Thiazolidinediones","volume":"26","author":"Ibrahim","year":"2023","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.108427_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196763","article-title":"Thiazolidin-2,4-Dione scaffold: an insight into recent advances as antimicrobial, antioxidant, and hypoglycemic Agents","volume":"27","author":"Kumar","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108427_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-8-S2-P82","article-title":"Molecular docking analysis of novel non-nucleoside reverse transcriptase inhibitors in development: implication for rational drug design","volume":"8","author":"Singh","year":"2011","journal-title":"Retrovirology"},{"key":"10.1016\/j.bioorg.2025.108427_bb0115","doi-asserted-by":"crossref","first-page":"A206","DOI":"10.1089\/aid.2014.5446.abstract","article-title":"Design and discovery of Pyrazole and pyrimidine as novel class of potent non-nucleoside reverse transcriptase inhibitors (NNRTIs)","volume":"30","author":"Singh","year":"2014","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.bioorg.2025.108427_bb0120","first-page":"829","article-title":"Discovery of novel 1,3,5-triazine derivatives as an antidiabetic agent in Wistar rats via inhibition of DPP-4, Future","volume":"15","author":"Gupta","year":"2023","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108427_bb0125","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1016\/j.bmcl.2014.05.103","article-title":"Structure-guided discovery of 1,3,5-triazine-pyrazole conjugates as antibacterial and antibiofilm agent against pathogens causing human diseases with favorable metabolic fate","volume":"24","author":"Singh","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108427_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22656","article-title":"Discovery of novel pyrazole derivatives as a potent anti-inflammatory agent in RAW264.7 cells via inhibition of NF-\u0138B for possible benefit against SARS-CoV-2","volume":"35","author":"Masih","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108427_bb0135","doi-asserted-by":"crossref","first-page":"17335","DOI":"10.1039\/c3ra41604f","article-title":"Phenyl hydrazone bearing pyrazole and pyrimidine scaffolds: design and discovery of a novel class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) against HIV-1 and their antibacterial properties","volume":"3","author":"Singh","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.108427_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.805187","article-title":"Structural Studies and structure activity relationships for novel computationally designed non-nucleoside inhibitors and their interactions with HIV-1 reverse transcriptase","volume":"9","author":"Frey","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bioorg.2025.108427_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbiomolbio.2004.07.001","article-title":"Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors","volume":"88","author":"Das","year":"2005","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.108427_bb0150","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.7b00524","article-title":"Discovery of novel Diarylpyrimidine derivatives as potent HIV-1 NNRTIs targeting the \u201cnNRTI adjacent\u201d binding site","volume":"9","author":"Huo","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108427_bb0155","article-title":"Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-d]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variants","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.108427_bb0160","doi-asserted-by":"crossref","DOI":"10.1248\/cpb.30.3580","article-title":"Synthesis of 5-[4-(1-Methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives","volume":"30","author":"Sohda","year":"1982","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.bioorg.2025.108427_bb0165","article-title":"Studies on the synthesis of some substituted flavonyl thiazolidinedione derivatives-I","volume":"23","author":"Bozda\u01e7","year":"1999","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.bioorg.2025.108427_bb0170","article-title":"Synthesis and antidiabetic activity of 2-amino [5\u2032(4- sulphonylbenzylidine)-2,4-thiazolidinedione]-7-chloro-6-fluorobenzothiazole","volume":"44","author":"Pattan","year":"2005","journal-title":"Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2025.108427_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bioorg.2025.108427_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135617","article-title":"Molecular hybrid of 1,2,3-triazole and schiff base as potential antibacterial agents: DFT, molecular docking and ADME studies","volume":"1286","author":"Belay","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108427_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/med.21760","article-title":"Druggability modification strategies of the diarylpyrimidine-type non-nucleoside reverse transcriptase inhibitors","volume":"41","author":"Ding","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.108427_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113051","article-title":"Exploiting the tolerant region I of the non-nucleoside reverse transcriptase inhibitor (NNRTI) binding pocket. Part 2: discovery of diarylpyrimidine derivatives as potent HIV-1 NNRTIs with high Fsp3 values and favorable drug-like properties","volume":"213","author":"Jiang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108427_bb0195","article-title":"The role of dynamic conformational ensembles in biomolecular recognition","volume":"5","author":"Boehr","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108427_bb0200","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.0c00761","article-title":"Boceprevir, Calpain inhibitors II and XII, and GC-376 have broad-Spectrum antiviral activity against coronaviruses","volume":"7","author":"Hu","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bioorg.2025.108427_bb0205","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.0c00216","article-title":"Identification of inhibitors of SARS-CoV-2 3CL-pro enzymatic activity using a small molecule in vitro repurposing screen","volume":"4","author":"Kuzikov","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bioorg.2025.108427_bb0210","article-title":"Bacterial co-infections in HIV\/AIDS-positive subjects: a systematic review and Meta-analysis","volume":"60","author":"Khademi","year":"2018","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.bioorg.2025.108427_bb0215","doi-asserted-by":"crossref","DOI":"10.1086\/596756","article-title":"HIV-associated opportunistic infections - going, going, but not gone: the continued need for prevention and treatment guidelines","volume":"48","author":"Brooks","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.108427_bb0220","first-page":"632","article-title":"Antibiotic resistance","volume":"49","author":"Edwards","year":"2021","journal-title":"Medicine (United Kingdom)"},{"key":"10.1016\/j.bioorg.2025.108427_bb0225","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00044-010-9446-7","article-title":"Synthesis and antibacterial evaluation of series of novel tri-substituted-s-triazine derivatives","volume":"20","author":"Singh","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.108427_bb0230","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1747-0285.2012.01433.x","article-title":"Design, facile synthesis, and antibacterial activity of hybrid 1,3,4-thiadiazole-1,3,5-triazine derivatives tethered via -S- bridge","volume":"80","author":"Dubey","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.108427_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11061614","article-title":"Microbial biofilm: a review on formation, infection, antibiotic resistance, control measures, and innovative treatment","volume":"11","author":"Sharma","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.bioorg.2025.108427_bb0240","series-title":"Bacterial Biofilms: A Common Cause of Persistent Infections, Science (1979) 284","author":"Costerton","year":"1999"},{"key":"10.1016\/j.bioorg.2025.108427_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/s41479-017-0036-z","article-title":"Atypical bacterial pneumonia in the HIV-infected population","volume":"9","author":"Head","year":"2017","journal-title":"Pneumonia"},{"key":"10.1016\/j.bioorg.2025.108427_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/S0968-0896(01)00366-2","article-title":"Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones","volume":"10","author":"Bruno","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108427_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaubas.2014.08.003","article-title":"Synthesis and biological evaluation of novel s-triazine based aryl\/heteroaryl entities: design, rationale and comparative study","volume":"20","author":"Mewada","year":"2016","journal-title":"Journal of the Association of Arab Universities for Basic and Applied Sciences"},{"key":"10.1016\/j.bioorg.2025.108427_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136478","article-title":"Discovery of novel hybrids of Morpholino-1,3,5-triazine-pyrimidine as an anti-diabetic agent in high-fat, low-dose Streptozotocin-induced diabetes in Wistar rats: an in-vitro, in-silico and in-vivo study","volume":"1294","author":"Gupta","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108427_bb0265","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1747-0285.2012.01430.x","article-title":"Design, synthesis, antibacterial activity, and molecular docking Studies of novel hybrid 1,3-Thiazine-1,3,5-Triazine derivatives as potential bacterial translation inhibitor","volume":"80","author":"Singh","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.108427_bb0270","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/157018011796575980","article-title":"Udaya Pratap Singh, facile synthesis, antibacterial activity and molecular properties prediction of some new 1,3-dihydroimidazol-2-thione derivatives","volume":"8","author":"Junejo","year":"2011","journal-title":"Lett Drug Des Discov"},{"key":"10.1016\/j.bioorg.2025.108427_bb0275","doi-asserted-by":"crossref","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2025.108427_b9000","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1073\/pnas.94.9.4653","article-title":"A new reporter cell line to monitor HIV infection and drug susceptibility in vitro","volume":"94","author":"Gervaix","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bioorg.2025.108427_bb0280","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone","volume":"59","author":"Adachi","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2025.108427_b9010","doi-asserted-by":"crossref","unstructured":"P.K. Kushwaha, K. S. Srivastava, N. Kumari, R. Kumar, D. Mitra, A. Sharon, Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs. Bioorg. Med. Chem. 56 (2022) 116612, https:\/\/doi.org\/ 10.1016\/j.bmc.2022.116612.","DOI":"10.1016\/j.bmc.2022.116612"},{"key":"10.1016\/j.bioorg.2025.108427_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115311","article-title":"Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: design, synthesis, biological evaluation, and X-ray structure determination","volume":"253","author":"Stefanelli","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108427_bb0290","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1747-0285.2012.01430.x","article-title":"Design, synthesis, antibacterial activity, and molecular docking Studies of novel hybrid 1,3-Thiazine-1,3,5-Triazine derivatives as potential bacterial translation inhibitor","volume":"80","author":"Singh","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.108427_bb0295","series-title":"Test No. 105: Water Solubility, Paris","author":"Organisation for Economic Cooperation and Development Guideline","year":"1995"}],"updated-by":[{"DOI":"10.1016\/j.bioorg.2025.108505","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000}}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825003074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825003074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:26:12Z","timestamp":1762223172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825003074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":61,"alternative-id":["S0045206825003074"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108427","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, and synthesis of 2,4-thiazolidinedione substituted 1,3,5-triazine derivatives as anti-HIV agent via inhibition of reverse transcriptase along with anti-SARS CoV-2, antibacterial and antibiofilm activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108427"}}